See more : Canoo Holdings Ltd. (GOEVW) Income Statement Analysis – Financial Results
Complete financial analysis of Medi Assist Health Ser L (MEDIASSIST.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Medi Assist Health Ser L, a leading company in the industry within the sector.
- Ovoca Bio plc (OVB.L) Income Statement Analysis – Financial Results
- FlashZero Corp. (FZRO) Income Statement Analysis – Financial Results
- Beijing Aerospace Changfeng Co.,Ltd (600855.SS) Income Statement Analysis – Financial Results
- Levere Holdings Corp. (LVRAW) Income Statement Analysis – Financial Results
- Suzhou UIGreen Micro&Nano Technologies Co.,Ltd (688661.SS) Income Statement Analysis – Financial Results
Medi Assist Health Ser L (MEDIASSIST.NS)
Website: https://www.mediassist.in
About Medi Assist Health Ser L
Medi Assist Healthcare Services Limited, together with its subsidiaries, provides third party administration services in India and internationally. It acts as a health-tech and insurance-tech company that manages health benefits for employers, retail members, and public health schemes, primarily serving insurance companies. The company also offers business support, health management, consultancy, contact center support, and other allied services related to the healthcare and health insurance sector. In addition, it provides pre-policy check-up and other allied services to insurance companies; and policy administration services to governments to enable public health schemes. The company was incorporated in 2000 and is based in Bengaluru, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 6.35B | 5.05B | 3.94B | 3.23B | 3.19B |
| Cost of Revenue | 3.73B | 1.98B | 2.01B | 1.67B | 1.35B |
| Gross Profit | 2.62B | 3.07B | 1.92B | 1.56B | 1.84B |
| Gross Profit Ratio | 41.28% | 60.85% | 48.84% | 48.28% | 57.66% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 459.77M | 299.85M | 230.31M | 204.36M | 0.00 |
| Selling & Marketing | 238.41M | 185.58M | 72.62M | 21.25M | 0.00 |
| SG&A | 698.18M | 485.43M | 302.93M | 225.61M | 0.00 |
| Other Expenses | 963.09M | 140.21M | 10.93M | 10.29M | 0.00 |
| Operating Expenses | 1.66B | 2.15B | 1.27B | 1.06B | 0.00 |
| Cost & Expenses | 5.39B | 4.12B | 3.28B | 2.73B | 1.35B |
| Interest Income | 107.82M | 41.68M | 31.29M | 130.34M | 0.00 |
| Interest Expense | 31.18M | 29.89M | 28.71M | 56.74M | 0.00 |
| Depreciation & Amortization | 430.77M | 267.69M | 284.08M | 316.59M | 111.73M |
| EBITDA | 1.31B | 1.33B | 1.12B | 974.61M | 625.00M |
| EBITDA Ratio | 20.58% | 26.41% | 24.93% | 29.61% | 19.62% |
| Operating Income | 958.97M | 1.07B | 697.59M | 638.89M | 1.84B |
| Operating Income Ratio | 15.11% | 21.11% | 17.71% | 19.80% | 57.66% |
| Total Other Income/Expenses | -115.10M | -6.79M | 37.41M | -1.02B | -1.24B |
| Income Before Tax | 843.87M | 1.04B | 806.87M | 610.42M | 594.50M |
| Income Before Tax Ratio | 13.30% | 20.52% | 20.49% | 18.91% | 18.66% |
| Income Tax Expense | 130.92M | 283.01M | 172.20M | 230.37M | 212.96M |
| Net Income | 669.39M | 740.42M | 642.18M | 262.74M | 335.50M |
| Net Income Ratio | 10.55% | 14.66% | 16.31% | 8.14% | 10.53% |
| EPS | 9.71 | 10.75 | 9.33 | 3.82 | 5.66 |
| EPS Diluted | 9.53 | 10.75 | 9.33 | 3.82 | 4.98 |
| Weighted Avg Shares Out | 68.93M | 68.86M | 68.86M | 68.86M | 59.28M |
| Weighted Avg Shares Out (Dil) | 70.20M | 68.86M | 68.86M | 68.86M | 67.40M |
Source: https://incomestatements.info
Category: Stock Reports